Hologic Inc (HOLX)

$73.99 +0.10 (0.14%)
Market Cap 16.43B
Revenue (ttm) 4.03B
Net Income (ttm) 789.50M
EPS (ttm) N/A
PE Ratio 17.81
Forward PE 16.51
Profit Margin 19.59%
Debt to Equity Ratio 0.52
Volume 5,163,300
Avg Vol 2,743,578
Day's Range N/A - N/A
Shares Out 222.42M
Stochastic %K 93%
Beta 0.63
Analysts Sell
Price Target $76.33

Company Profile

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, an...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 508 263 2900
Address:
250 Campus Drive, Marlborough, United States
Goldennight29
Goldennight29 Oct. 25 at 4:20 PM
$HOLX
0 · Reply
IN0V8
IN0V8 Oct. 23 at 3:00 PM
$HOLX Mizuho cuts to neutral from outperform Mizuho raises target price to $78 from $70 Stephens cuts target price to $76 from $78 Stephens cuts to equal-weight from overweight
0 · Reply
Tat2doc
Tat2doc Oct. 23 at 1:51 PM
$HOLX surprised this hasn’t gone further with a guaranteed $76 + ~$3 in revenue targets agreed to by $BX. Argus set a price target of $90 back in September. Should be interesting to watch.
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 11:55 AM
Mizuho has adjusted their stance on Hologic ( $HOLX ), setting the rating to Neutral with a target price of 70 → 78.
0 · Reply
r3y
r3y Oct. 23 at 8:42 AM
$HOLX 80
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 3:52 PM
Raymond James has updated their rating for Hologic ( $HOLX ) to Market Perform.
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 3:46 PM
Stephens & Co. updates rating for Hologic ( $HOLX ) to Equal-Weight, target set at 78 → 76.
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 11:01 AM
JP Morgan has updated their rating for Hologic ( $HOLX ) to Neutral with a price target of 78.
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 8:46 PM
Leerink Partners has updated their rating for Hologic ( $HOLX ) to Market Perform with a price target of 78.
0 · Reply
mwinc24
mwinc24 Oct. 21 at 7:39 PM
$HOLX 11/21 $75 calls. Lets see where it goes
0 · Reply
Latest News on HOLX
Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX

Oct 22, 2025, 4:56 PM EDT - 2 days ago

Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

Oct 21, 2025, 9:18 AM EDT - 4 days ago

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

BX TPG

Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal

Oct 21, 2025, 8:48 AM EDT - 4 days ago

Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal

BX TPG

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

Oct 21, 2025, 8:41 AM EDT - 4 days ago

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks

Oct 20, 2025, 7:55 AM EDT - 5 days ago

Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks

BX TPG

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

Oct 2, 2025, 4:04 PM EDT - 22 days ago

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

Oct 2, 2025, 8:05 AM EDT - 23 days ago

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

New Survey Results Underscore the Need to #BustTheMyth About Mammograms

Sep 30, 2025, 8:15 AM EDT - 25 days ago

New Survey Results Underscore the Need to #BustTheMyth About Mammograms

Volition Signs Co-Marketing and Services Agreement with Hologic

Sep 29, 2025, 9:30 AM EDT - 26 days ago

Volition Signs Co-Marketing and Services Agreement with Hologic

VNRX

Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

Sep 29, 2025, 9:30 AM EDT - 26 days ago

Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI

Sep 26, 2025, 8:00 AM EDT - 4 weeks ago

New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI

Blackstone and TPG revive interest in buying Hologic, source says

Sep 17, 2025, 4:41 PM EDT - 5 weeks ago

Blackstone and TPG revive interest in buying Hologic, source says

BX TPG

Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 2:05 PM EDT - 6 weeks ago

Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

Sep 3, 2025, 4:02 PM EDT - 7 weeks ago

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript

Jul 30, 2025, 7:12 PM EDT - 3 months ago

Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript

Hologic raises annual profit forecast on diagnostic and surgical demand

Jul 30, 2025, 6:06 PM EDT - 3 months ago

Hologic raises annual profit forecast on diagnostic and surgical demand

Hologic Announces Financial Results for Third Quarter of Fiscal 2025

Jul 30, 2025, 4:01 PM EDT - 3 months ago

Hologic Announces Financial Results for Third Quarter of Fiscal 2025

Hologic Q3 Preview: Tariff Pressure And Undervalued Stock Price, Initiate With Buy

Jul 22, 2025, 5:06 PM EDT - 3 months ago

Hologic Q3 Preview: Tariff Pressure And Undervalued Stock Price, Initiate With Buy

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

Jul 2, 2025, 4:05 PM EDT - 4 months ago

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

Jun 2, 2025, 11:03 AM EDT - 5 months ago

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

May 27, 2025, 3:48 PM EDT - 5 months ago

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

May 27, 2025, 1:05 PM EDT - 5 months ago

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

BX TPG

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

May 22, 2025, 5:05 PM EDT - 5 months ago

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

Hologic to Webcast Presentations at Upcoming Investor Conferences

May 13, 2025, 4:10 PM EDT - 5 months ago

Hologic to Webcast Presentations at Upcoming Investor Conferences

Hologic: Soft Performance, But Cheap Enough

May 6, 2025, 5:39 PM EDT - 6 months ago

Hologic: Soft Performance, But Cheap Enough

Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript

May 1, 2025, 8:24 PM EDT - 6 months ago

Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript

Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty

May 1, 2025, 6:58 PM EDT - 6 months ago

Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

May 1, 2025, 4:01 PM EDT - 6 months ago

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More

Apr 25, 2025, 4:25 AM EDT - 6 months ago

Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Apr 24, 2025, 8:10 AM EDT - 6 months ago

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report

Apr 22, 2025, 8:08 AM EDT - 6 months ago

Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report

Wayde McMillan Elected to Hologic Board of Directors

Apr 4, 2025, 4:15 PM EDT - 7 months ago

Wayde McMillan Elected to Hologic Board of Directors

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Apr 3, 2025, 4:30 PM EDT - 7 months ago

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

Feb 25, 2025, 8:15 AM EST - 8 months ago

Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Feb 20, 2025, 3:00 AM EST - 8 months ago

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Feb 18, 2025, 8:08 AM EST - 8 months ago

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Hologic, Inc. (HOLX) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 10:06 PM EST - 9 months ago

Hologic, Inc. (HOLX) Q1 2025 Earnings Call Transcript

Hologic cuts annual revenue forecast on weak demand for breast health products

Feb 5, 2025, 5:56 PM EST - 9 months ago

Hologic cuts annual revenue forecast on weak demand for breast health products

Hologic Announces Financial Results for First Quarter of Fiscal 2025

Feb 5, 2025, 4:01 PM EST - 9 months ago

Hologic Announces Financial Results for First Quarter of Fiscal 2025

New Report Reveals Alarming Decline in Women's Cancer Testing Worldwide

Jan 21, 2025, 8:00 AM EST - 9 months ago

New Report Reveals Alarming Decline in Women's Cancer Testing Worldwide

Hologic: Reasonably, But Not Compellingly Valued

Jan 17, 2025, 1:28 PM EST - 10 months ago

Hologic: Reasonably, But Not Compellingly Valued

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025

Jan 12, 2025, 4:00 PM EST - 10 months ago

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025

Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 4:04 PM EST - 10 months ago

Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025

Jan 6, 2025, 4:15 PM EST - 10 months ago

Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025

Hologic Completes Acquisition of Gynesonics, Inc.

Jan 6, 2025, 8:05 AM EST - 10 months ago

Hologic Completes Acquisition of Gynesonics, Inc.

Healthcare has 'been so bad, maybe it's gonna be good' in 2025, says Mizuho's Jared Holz

Jan 3, 2025, 12:06 PM EST - 10 months ago

Healthcare has 'been so bad, maybe it's gonna be good' in 2025, says Mizuho's Jared Holz

ABT BMY LLY NVO UNH XBI XLV

Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC

Dec 18, 2024, 8:08 AM EST - 11 months ago

Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC

Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines

Dec 10, 2024, 4:01 PM EST - 11 months ago

Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines

Goldennight29
Goldennight29 Oct. 25 at 4:20 PM
$HOLX
0 · Reply
IN0V8
IN0V8 Oct. 23 at 3:00 PM
$HOLX Mizuho cuts to neutral from outperform Mizuho raises target price to $78 from $70 Stephens cuts target price to $76 from $78 Stephens cuts to equal-weight from overweight
0 · Reply
Tat2doc
Tat2doc Oct. 23 at 1:51 PM
$HOLX surprised this hasn’t gone further with a guaranteed $76 + ~$3 in revenue targets agreed to by $BX. Argus set a price target of $90 back in September. Should be interesting to watch.
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 11:55 AM
Mizuho has adjusted their stance on Hologic ( $HOLX ), setting the rating to Neutral with a target price of 70 → 78.
0 · Reply
r3y
r3y Oct. 23 at 8:42 AM
$HOLX 80
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 3:52 PM
Raymond James has updated their rating for Hologic ( $HOLX ) to Market Perform.
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 3:46 PM
Stephens & Co. updates rating for Hologic ( $HOLX ) to Equal-Weight, target set at 78 → 76.
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 11:01 AM
JP Morgan has updated their rating for Hologic ( $HOLX ) to Neutral with a price target of 78.
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 8:46 PM
Leerink Partners has updated their rating for Hologic ( $HOLX ) to Market Perform with a price target of 78.
0 · Reply
mwinc24
mwinc24 Oct. 21 at 7:39 PM
$HOLX 11/21 $75 calls. Lets see where it goes
0 · Reply
biostock
biostock Oct. 21 at 7:28 PM
$HOLX Show me $79. $SPY $QQQ
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 21 at 6:16 PM
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market $IZO.CN $IZOZF $HOLX $GEHC $NNOX $ORCL https://ibn.fm/0iPjb
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 4:30 PM
Enter: $HOLX NOV 21 2025 $72 CALLS Buy in Price: $1.55 - $1.63 Take Profit: $2.34 Stop Bleeding: $1.36 ROI Potential: 51% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 3:38 PM
BTIG has adjusted their stance on Hologic ( $HOLX ), setting the rating to Neutral.
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 3:27 PM
Needham has adjusted their stance on Hologic ( $HOLX ), setting the rating to Hold.
0 · Reply
PoorOffTrading
PoorOffTrading Oct. 21 at 2:23 PM
$HOLX I find weird that the named a company that makes med devices equipment for women Hologic.
0 · Reply
notreload_ai
notreload_ai Oct. 21 at 1:56 PM
Blackstone and TPG are acquiring women's health leader $HOLX for up to $18.3 billion in one of 2025's largest healthcare buyouts, with shareholders receiving $76-$79 per share. https://notreload.xyz/blackstone-tpg-hologic-healthcare-deal/
0 · Reply
notreload_ai
notreload_ai Oct. 21 at 1:41 PM
BREAKING: $HOLX to go private in up to $18.3 billion deal backed by Blackstone, TPG
0 · Reply
longandon
longandon Oct. 21 at 12:55 PM
$HOLX 76+ cvr worth potentially 3..hmm
0 · Reply
longandon
longandon Oct. 21 at 12:50 PM
$HOLX 79 bucks...a little off. Congrats everyone.
0 · Reply
longandon
longandon Oct. 21 at 12:39 PM
$HOLX it's halted, what's the news?
0 · Reply
Vapor83
Vapor83 Oct. 21 at 4:44 AM
$HOLX best guess, if the deal proceeds, is $81/share
0 · Reply